WEBINAR: Uncovering unmet need: Using real-time RWD to close gaps in care and access – VIEW ON DEMAND
Learn how daily-updated, real-world data with provider- and site-level insights can uncover gaps in care and access, prioritize engagement efforts, and support patient-centered initiatives.
A clear understanding of unmet need in real-world care is essential for life sciences—from patients who go undiagnosed or untreated, to those who experience barriers to access, suboptimal adherence, or delayed intervention. In this webinar, Truveta will demonstrate how daily updated real-world data can be used to identify unmet need across the care continuum. Using provider- and site-level insights, attendees will learn how researchers can analyze diagnostic pathways, treatment patterns, and access disparities to reveal opportunities to inform responsible, evidence-based engagement strategies focused on improving patient outcomes.
What you will learn
- How to analyze unmet needs in real-world care by identifying gaps in diagnosis, treatment initiation, and access
- To identify missed opportunities for earlier intervention through analysis of diagnostic pathways and treatment journeys
- Ways to evaluate disparities in access and utilization across demographics, geography, and payer types
- How to interpret real-time insights into adherence, discontinuation, and switching to inform patient support and engagement strategies
- Opportunities to apply daily updated real-world data to support medical affairs, market access, and field engagement through provider- and site-level visibility
Speakers
Johnathan M Lancaster, MD, PhD
President and Chief Scientific Officer, Truveta
Johnathan Lancaster, MD, PhD is President and Chief Scientific Officer at Truveta. Previously, Dr Lancaster served as Senior Vice President and Head of Global Medical Affairs at Regeneron, Global Chief Medical Officer at Myriad Genetics, and spent more than a decade at Moffitt Cancer Center as a gynecologic oncologist, translational researcher, Chair of Women’s Oncology, and President of the Moffitt Medical Group.
A graduate of the University of Cambridge and Duke University, Dr Lancaster is a pioneer in cancer genomics and personalized medicine, has authored over 100 peer-reviewed publications, and holds eight patents in cancer detection and therapeutics.
Nina Masters, PhD, MPH
Senior Applied Research Scientist, Truveta
Nina Masters, PhD, MPH, is a Senior Applied Research Scientist at Truveta, leading research to advance insight into infectious disease, maternal health, and other public health topics. Prior to Truveta, Dr Masters served in numerous government and academic roles—including as a CDC vaccine epidemiologist and modeler—and has extensive background in outbreak response, vaccine impact modeling, and public health strategy and policy. She earned her PhD and MPH from the University of Michigan School of Public Health and her bachelor’s degree in Chemistry from Princeton University.
In association with
If you are interested in partnering with The Evidence Base for future webinars, please contact [email protected].